MENU
OCUL
AS OF
Jan 14, 04:59 PM (EDT)
Price
$11.09
Change
+$0.66 (+6.33%)
Capitalization
2.22B
53 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
OCUL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ocular Therapeutix (OCUL) Ownership - Who owns Ocular Therapeutix?

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Other
Address
15 Crosby Drive
Phone
+1 781 357-4000
Employees
267
Web
https://www.ocutx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.22B
P/E Ratio
N/A
Total Cash
344.77M
Projected Growth
N/A
Total Debt
77.01M
Revenue
55.78M
Risk (Beta)
1.95
Dividend Yield
N/A
Total Cash/Share
1.62
Total Debt/Equity
N/A
Revenue/Share
0.32 USD as % of share price

Fundamentals

OCUL
Capitalization
2.22B
P/E Ratio
N/A
Risk (Beta)
1.95
Dividend Yield
N/A
Total Cash
345M
Total Cash/Share
1.62
Total Debt
77M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.32%
Revenue
55.8M
ROE
N/A
Book Value
258M
P/B Ratio
8.61
Cash Flow
N/A
Earnings
-1.43
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
18K
Current Ratio
7.85
Current Revenue Per Employee
53080.29
Dividends Per Share - Security
N/A
EBITDA
-233.54M
Float
N/A
Float - Current
N/A
Gross Income Margin
87.80
Revenue To Assets
-55.41
Shares Held By Institutions
2.92B
Shares Outstanding - Current
213M
Total Liabilities
153M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-14.086
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
OCUL
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. OCUL showed earnings on November 04, 2025. You can read more about the earnings report here.
View AI-Driven Trading for OCUL
A.I. Advisor
published General Information

General Information

a developer of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
15 Crosby Drive
Phone
+1 781 357-4000
Employees
267
Web
https://www.ocutx.com